LAMC2 Gene Epidermolysis Bullosa Junctional Genetic Test
At DNA Labs UAE, we offer the LAMC2 Gene Epidermolysis Bullosa Junctional Genetic Test for individuals suspected of having this rare inherited skin disorder. This test can help diagnose and provide valuable information for prognosis and genetic counseling.
Test Details
The LAMC2 gene is associated with Epidermolysis Bullosa Junctional (EB-J), a genetic disorder characterized by blistering and erosions of the skin and mucous membranes. It is caused by mutations in genes involved in the structure and function of the skin.
Our LAMC2 Gene Epidermolysis Bullosa Junctional Genetic Test utilizes Next-Generation Sequencing (NGS) technology, which allows for the simultaneous analysis of multiple genes or the entire genome. This test can identify mutations in the LAMC2 gene and other genes associated with EB-J.
To perform the test, we require a DNA sample, which can be obtained through a blood or saliva sample. The DNA is then sequenced to identify any mutations or variations in the LAMC2 gene.
Test Components and Price
- Test Name: LAMC2 Gene Epidermolysis Bullosa Junctional Genetic Test
- Components: NGS Technology
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Test Type: Osteology Dermatology Immunology Disorders
- Doctor: Dermatologist
- Test Department: Genetics
Pre Test Information
Prior to the LAMC2 Gene Epidermolysis Bullosa Junctional Genetic Test, we recommend a genetic counseling session to gather the clinical history of the patient and draw a pedigree chart of family members affected by EB-J. This information can help in the interpretation of test results and provide a comprehensive understanding of the genetic makeup of the family.
Uses of NGS Genetic Testing for EB-J
NGS genetic testing for the LAMC2 gene in the context of EB-J can provide valuable information for various purposes:
- Diagnosis: Confirm a diagnosis of EB-J and identify the specific genetic changes causing the disorder.
- Prognosis: Understand the severity and progression of the disease based on the identified mutations.
- Genetic Counseling: Provide information and guidance to individuals and families affected by EB-J.
- Carrier Testing: Identify individuals who carry a mutation in the LAMC2 gene but may not have any symptoms of the disorder themselves.
- Prenatal Testing: Offer testing during pregnancy to determine if the fetus has inherited the mutation.
- Preimplantation Genetic Diagnosis: Assist in selecting embryos free of the LAMC2 gene mutation for implantation during in vitro fertilization.
Overall, NGS genetic testing for the LAMC2 gene in the context of EB-J can significantly contribute to the diagnosis, prognosis, and genetic counseling for individuals and families affected by this rare genetic disorder.
| Test Name | LAMC2 Gene Epidermolysis bullosa junctional Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for LAMC2 Gene Epidermolysis bullosa, junctional NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with LAMC2 Gene Epidermolysis bullosa, junctional NGS Genetic DNA Test gene LAMC2 |
| Test Details | The LAMC2 gene is associated with a genetic disorder called Epidermolysis bullosa, junctional (EB-J). EB-J is a rare inherited skin disorder characterized by blistering and erosions of the skin and mucous membranes. It is caused by mutations in genes involved in the structure and function of the skin. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or the entire genome. In the context of EB-J, NGS genetic testing can be used to identify mutations in the LAMC2 gene and other genes associated with the disorder. NGS genetic testing for EB-J typically involves obtaining a DNA sample, usually through a blood or saliva sample, and then sequencing the DNA to identify any mutations or variations in the LAMC2 gene. This can help confirm a diagnosis of EB-J and provide information about the specific genetic changes causing the disorder. NGS genetic testing can also be used for carrier testing, prenatal testing, or preimplantation genetic diagnosis in families with a history of EB-J. It can help identify individuals who carry a mutation in the LAMC2 gene but may not have any symptoms of the disorder themselves. Overall, NGS genetic testing for the LAMC2 gene in the context of EB-J can provide valuable information for diagnosis, prognosis, and genetic counseling for individuals and families affected by this rare genetic disorder. |
